Lb Pharmaceuticals Inc · NASDAQ:LBRX
BlackRock, Inc. reported a 5.10% stake in Lb Pharmaceuticals Inc (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 5.10% stake in Lb Pharmaceuticals Inc, 1,277,776 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 1,277,776
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.10% | 1,277,776 |
Source
Related
- Lb Pharmaceuticals Inc
- BlackRock, Inc.
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G · Caligan Partners LP · May 15, 2026